The volume of recent flu infections and related hospitalizations is higher than what Sonoma County epidemiologists have ...

Dr. Michael Reihart, with Penn State Health, also explained who's most at risk for severe illness and how effective this year's vaccine is.

Public Health Sudbury and Districts said Friday that outbreaks of respiratory and gastrointestinal illness are on the rise. Higher levels of sickness are being reported for influenza and enteric ...

Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

Here are four more respiratory illness updates: Nearly 1.7% of all deaths nationwide were attributed to flu, compared to approximately 1.5% from COVID-19. Influenza test positivity rose to 31.6%, ...

Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

The U.S. has seen earlier and more intense surges of the flu and RSV this year than is typical, pediatrician Dr. Ryan Fulton ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Babies under 8 months old are eligible to get an RSV vaccine, and women who are pregnant can also get it to protect kids before they're born. The vaccine is available now through March. If you have ...

Pope Francis was hospitalized Friday for the fourth time since he was elected in 2013. Francis, who was diagnosed with ...

Moderna Inc. recorded another quarterly loss as vaccine sales wane and the company had an unexpected charge for a canceled manufacturing contract.

We recently published a list of 7 Best Nanotech Penny Stocks to Invest In. In this article, we are going to take a look at ...